EUVIMEDEUVIMED entdecken
Crossref

Virus-Like Particle-Based Personalized Neoantigen Nano-Vaccine for Tumor Immunotherapy and Recurrence Prevention

Shujun Zhou, Chufan Wang, Yuxiang Ning, Yunhao Wang, Fei Xin, Lei Ren iD, Yanfeng Wang iD

ACS Nano · 2025

DOI: 10.1021/acsnano.5c06278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Shujun Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Immunotherapy, Cancer Vaccines, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Zhongnan Hospital of Wuhan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCancer VaccinesCarcinoma, HepatocellularLiver NeoplasmsAntigens, NeoplasmVaccines, Virus-Like ParticleNeoplasm Recurrence, LocalAnimalsHumansMicePrecision MedicineCell Line, TumorMice, Inbred BALB CFemaleNanoparticlesNanovaccines

Stichwörter der Autor:innen

hepatitis B core protein virus-like particlesimmunotherapyneoantigentumor recurrencetumor vaccines

Substanzen

Cancer VaccinesAntigens, NeoplasmVaccines, Virus-Like ParticleNanovaccines

Autor:innen und Institutionen

  • Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Jingzhou Central Hospital, Jingzhou 434020, China.
  • College of Chemistry and Molecular Sciences, Hubei Engineering Center of Natural Polymer-Based Medical Materials, Wuhan University, Wuhan 430072, China.
  • The Higher Educational Key Laboratory for Biomedical Engineering of Fujian Province, Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University, Xiamen 36100…
  • State Key Laboratory of Physical Chemistry of Solid Surface, School of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, People's Republic of China.

ORCID-Profile: Lei Ren, Yanfeng Wang

Förderung

  • Zhongnan Hospital of Wuhan University

Zitieren

APA

Zhou, S., Wang, C., Ning, Y., Wang, Y., Xin, F., Ren, L., & Wang, Y. (2025). Virus-Like Particle-Based Personalized Neoantigen Nano-Vaccine for Tumor Immunotherapy and Recurrence Prevention. ACS Nano. https://doi.org/10.1021/acsnano.5c06278

Vancouver

Zhou S, Wang C, Ning Y, Wang Y, Xin F, Ren L, et al. Virus-Like Particle-Based Personalized Neoantigen Nano-Vaccine for Tumor Immunotherapy and Recurrence Prevention. ACS Nano. 2025. doi:10.1021/acsnano.5c06278

BibTeX
@article{Zhou2025,
  author = {Zhou, Shujun and Wang, Chufan and Ning, Yuxiang and Wang, Yunhao and Xin, Fei and Ren, Lei and Wang, Yanfeng},
  title = {Virus-Like Particle-Based Personalized Neoantigen Nano-Vaccine for Tumor Immunotherapy and Recurrence Prevention},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.5c06278}
}
Kostenlos starten →